NEOS Investment Management LLC Buys 24,888 Shares of Kenvue Inc. (NYSE:KVUE)

NEOS Investment Management LLC raised its position in Kenvue Inc. (NYSE:KVUE - Free Report) by 31.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 103,849 shares of the company's stock after acquiring an additional 24,888 shares during the period. NEOS Investment Management LLC's holdings in Kenvue were worth $2,217,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. UniSuper Management Pty Ltd raised its holdings in shares of Kenvue by 3.1% in the 4th quarter. UniSuper Management Pty Ltd now owns 1,248,543 shares of the company's stock worth $26,656,000 after acquiring an additional 37,802 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in shares of Kenvue by 4.2% in the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,609,212 shares of the company's stock worth $76,515,000 after purchasing an additional 143,861 shares during the last quarter. Graney & King LLC bought a new position in shares of Kenvue in the fourth quarter valued at approximately $114,000. TrueMark Investments LLC boosted its position in shares of Kenvue by 9.3% during the fourth quarter. TrueMark Investments LLC now owns 190,595 shares of the company's stock valued at $4,069,000 after buying an additional 16,161 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. raised its position in Kenvue by 3.2% in the 4th quarter. Meiji Yasuda Asset Management Co Ltd. now owns 65,376 shares of the company's stock valued at $1,396,000 after buying an additional 2,041 shares during the last quarter. Institutional investors own 97.64% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

KVUE has been the subject of a number of recent analyst reports. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $24.00 price objective on shares of Kenvue in a research report on Monday, February 3rd. Deutsche Bank Aktiengesellschaft downgraded shares of Kenvue from a "buy" rating to a "hold" rating and cut their price target for the stock from $25.00 to $24.00 in a report on Thursday, December 12th. Piper Sandler raised their price objective on shares of Kenvue from $24.00 to $27.00 and gave the stock an "overweight" rating in a report on Monday, February 24th. Canaccord Genuity Group boosted their target price on shares of Kenvue from $24.00 to $29.00 and gave the company a "buy" rating in a research note on Wednesday, March 5th. Finally, Barclays raised their price target on shares of Kenvue from $21.00 to $23.00 and gave the stock an "equal weight" rating in a research note on Thursday, March 27th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $24.00.

Kenvue Price Performance

Shares of KVUE traded up $0.09 during trading hours on Wednesday, reaching $23.97. 5,675,793 shares of the company's stock traded hands, compared to its average volume of 16,704,100. Kenvue Inc. has a 12 month low of $17.67 and a 12 month high of $24.46. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $45.80 billion, a PE ratio of 45.10, a price-to-earnings-growth ratio of 2.62 and a beta of 1.25. The firm's 50 day simple moving average is $22.44 and its 200-day simple moving average is $22.46.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.26 EPS for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. Equities analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th were issued a dividend of $0.205 per share. The ex-dividend date was Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.42%. Kenvue's dividend payout ratio is 154.72%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.